Results

Total Results: 1,229 records

Showing results for "adverse event".
Users also searched for: patient safety indicators

1. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
   March 01, 2024 - Serious adverse events, convalescent plasma, 45 days or less Serious Adverse Event Study ID Days … Serious adverse events, convalescent plasma, more than 45 days Serious Adverse Event Study ID Days … Serious adverse events, nirmatrelvir and ritonavir Serious Adverse Event Study ID Days n/N … Serious adverse events, molnupiravir Serious Adverse Event Study ID Days n/N Intervention n … Serious adverse events, bebtelovimab Serious Adverse Event Study ID Days n/N Intervention n

2. Adverse Events Associated with COVID-19 Pharmaceutical Treatments (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
   December 23, 2023 - events  Common Terminology Criteria for Adverse Events (CTCAE) severity category3  CTCAE event … instrument4: whether reporting was passive (i.e., outpatients contacted researchers if they experienced an event … pre-determined list of events); whether the authors report the proportion of patients experiencing each event … event or death. … Adverse effects of vaccines: evidence and causality. 2012 VI.

3. S108 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
   October 01, 2007 - That is, once the adverse event was experienced, the adverse event status variable was set to the value … an adverse event. … status alone; (2) adverse event status plus baseline severity; (3) adverse event status plus lagged … adverse event, the probability of the observed adverse event status was equal to 1 minus the probability … of experiencing an adverse event.

4. Cover Page (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
   September 01, 2007 - Keywords: Adverse event reporting, community pharmacy safety network, post-marketing surveillance … In a 1996 article titled “The Clinical Impact of Adverse Event Reporting” the FDA estimated that only … In Section 3, we review previous literature discussing technological solutions to the adverse event … stored in the Adverse Event Reporting System (AERS) database. … still under-perform chart review based methods for adverse event detection.

5. Cover Page (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
   September 01, 2007 - Keywords: Adverse event reporting, community pharmacy safety network, post-marketing surveillance … In a 1996 article titled “The Clinical Impact of Adverse Event Reporting” the FDA estimated that only … In Section 3, we review previous literature discussing technological solutions to the adverse event … stored in the Adverse Event Reporting System (AERS) database. … still under-perform chart review based methods for adverse event detection.

6. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
   January 01, 2011 - event related to drug use), and additional costs to patients (out-of-pocket). … (4 criteria, 6 comparisons) 7 Adverse event 1/3 1 1/3 1/5 Treatment impact 5 Reciprocal … event Treatment impact Co- payment Average Clinical benefit 0.15 0.42 0.75 0.63 … 0.49 Adverse event 0.05 0.14 0.05 0.02 0.06 Treatment impact 0.77 0.42 0.15 0.27 … Other serious adverse events • Adverse events, which points to: o Sexual dysfunction o Other adverse

7. Dia 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
   January 01, 2011 - Events high blood pressure high blood pressure No adverse events Out-of-Pocket Costs 5 US$ … Events high blood pressure high blood pressure No adverse events Out-of-Pocket Costs 5 US$ … event Treatment impact Co-payment Clinical benefit 1 3 5 7 Adverse event 1/3 1 1/3 1/5 Treatment … event Treatment impact Co-payment Clinical benefit 0.15 0.42 0.75 0.63 Adverse event 0.05 0.14 0.05 … events Disease specific QoL Adverse events Serious adverse events Adverse events Prioritize

8. S96 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
   October 01, 2007 - –S102) An adverse drug event (ADE) occurs when a drug intended for therapeutic use has an unintended … Event Surveil- lance project (NEISS-CADES). … Adverse drug event data collection, National Elec- tronic Injury Surveillance System-Cooperative Adverse … Assessing the national electronic injury surveillance system-cooperative adverse drug event surveillance … The FDA safety information and adverse event reporting program.

9. Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
   November 01, 2023 - event was higher with posterior approaches than ACDF in patients with 3 or more level disease (SOE: … event; BMP-2 = bone morphogenetic protein 2; CDD = cervical degenerative disease; EMS = electromagnetic … event; SOE = strength of evidence; T2 = T2 weighted image Strength of Evidence: low (+), moderate … However, there were some differences in the frequency of adverse events for some comparisons. … Limited evidence also suggests a lower likelihood of experiencing any serious adverse event with ACDF

10. 8 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - adverse event, which may be critical to any decisions. … event” should generally be the default term over “adverse effect” or “adverse reaction/adverse drug … Serious adverse event Any adverse event with serious medical consequences, including death, hospital … Severe adverse event An adverse event whose intensity is considered severe (including “nonserious” adverse … event and adverse event appearing at an appropriate time interval after exposure) Lack of alternative

11. 8 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - adverse event, which may be critical to any decisions. … event” should generally be the default term over “adverse effect” or “adverse reaction/adverse drug … Serious adverse event Any adverse event with serious medical consequences, including death, hospital … Severe adverse event An adverse event whose intensity is considered severe (including “nonserious” adverse … event and adverse event appearing at an appropriate time interval after exposure) Lack of alternative

12. App-E-Surv-Report-3-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
    May 29, 2025 - B Any adverse event: 13.6% (11/81) vs. 18.6% (16/86) NR NR Fair Abbreviations: CI = confidence interval … B Any adverse event: 10.0% (6/60) vs. 18.6% (11/59), RR 0.54 (95% CI 0.21 to 1.36) Nausea: 0.8% (1/60 … B Any adverse event: 34% (26/76) vs. 9% (7/74), RR 3.62 (95% CI 1.67 to 7.82) Dizziness: 7.9% (6/76) … B Any adverse event: 11.6% (8/69) vs. 13.2% (9/68), p=0.57 NR Institutional grant Fair Frants, 2021 … B Any adverse event: 52.7% (15/36) vs. 8.8% (3/34), p=0.002 Any severe adverse event: 16.7% (6/36) vs

13. App-E-Surv-Report-2-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
    May 29, 2025 - B Any adverse event: 13.6% (11/81) vs. 18.6% (16/86) NR NR Fair Abbreviations: CI = confidence interval … B Any adverse event: 10.0% (6/60) vs. 18.6% (11/59), RR 0.54 (95% CI 0.21 to 1.36) Nausea: 0.8% (1/60 … B Any adverse event: 34% (26/76) vs. 9% (7/74), RR 3.62 (95% CI 1.67 to 7.82) Dizziness: 7.9% (6/76) … B Any adverse event: 11.6% (8/69) vs. 13.2% (9/68), p=0.57 NR Institutional grant Fair Frants, 2021 … B Any adverse event: 52.7% (15/46) vs. 8.8% (3/34), p=0.002 Any severe adverse event: 16.7% (6/36) vs

14. S89 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
    October 01, 2007 - In addition, for a rare adverse event, analysis using matched controls may not provide the earliest possible … event. … Safety data on meningococcal poly- saccharide vaccine from the Vaccine Adverse Event Reporting System … Poisson sequential sampling modified towards maximal safety in adverse event monitoring. … A maximized sequential probability ratio test for drug and vaccine adverse event surveillance.

15. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - Of note, a directly asserted association between adverse event and medical intervention may not be present … event). … events, defined as any treatment-related adverse event (see list above) that occurs > 30 days post-treatment … event and is captured under Clinical Response. … Events of Interest Adverse events associated with disease progression Adverse events associated with

16. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - Of note, a directly asserted association between adverse event and medical intervention may not be present … event). … events, defined as any treatment-related adverse event (see list above) that occurs > 30 days post-treatment … event and is captured under Clinical Response. … Events of Interest Adverse events associated with disease progression Adverse events associated with

17. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - The current CTCAE system (version 5) differentiates 837 adverse events within 26 adverse event domains … event assessment (e.g., use of a scale or checklist) and whether adverse event data were … KQ3b, i.e., to determine whether a specific adverse event is associated with a vaccine. … Common Terminology Criteria for Adverse Events classification system (CTCAE) adverse event domains … Common Terminology Criteria for Adverse Events classification system (CTCAE) adverse event domains

18. CER 220 Evidence Summary: Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - Analytic framework Abbreviations: AE=adverse event; KQ=Key Question Data Sources We searched MEDLINE … event, hypotension, mental status changes, and respiratory depression). … The IN route was also common in studies reporting adverse event outcomes for the comparison of opioids … event” where analgesics were primarily administered IN. … that at least 50 percent of treated patients will experience some type of adverse event but low-strength

19. Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review. Evidence Summary. (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
    November 01, 2017 - pharmacologic and nonpharmacologic treatments for depression in adult patients within 3 months of an ACS event … Clinical outcomes Response or remission Cardiac-related outcomes – Cardiac mortality Repeat ACS event … cardiovascular event (MACE) cardiac mortality, all- cause mortality, repeat ACS, revascularization, … or hospitalization in individuals following an ACS event Table D. … cardiovascular event; MCS=mental component summary; MI=myocardial infarction; NR=not reported; RCT=

20. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … Some nonopioid treatments had frequent overall adverse events and some less frequent yet serious adverse … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … Understanding how the adverse event profiles of cannabis products compare with other available treatments … In order to better understand the small to moderate improvements in pain, and the complete adverse event